To assess possible function of augmented IGFBP6+ CAF abundance in CRC patients, we conducted pathway enrichment analysis, and revealed that the ECM and signal transduction networks in absence of ligand were remarkably enriched (Fig. 4D). This evidence concerns the gene IGFBP6 and colorectal carcinoma.